Posts Tagged ‘FDA’

IMPORTANT ANTIMICROBIALS TRANSITION TO PRESCRIPTION STATUS Starts June 11th, 2023 – FDA GFI #263  WHY IS FDA ISSUING THIS GUIDANCE? Guidance for industry (GFI) #263 is part of a broader effort by FDA to combat antimicrobial resistance (AMR), a serious threat to animal and public health. Antimicrobial use in humans, animals, and horticulture can contribute…